Literature DB >> 17190640

Acute myelogenous leukemia in a patient receiving etanercept for psoriasis.

Claude Bachmeyer, Brigitte Thiolière, Kiarash Khosrotehrani, Elie Cattan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17190640     DOI: 10.1016/j.jaad.2006.06.032

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

1.  TNF-alpha inhibitors and leukaemia: international pharmacovigilance reports.

Authors:  Ronald H B Meyboom; Kristina Star; Jenny Bate; Ruth Savage; I Ralph Edwards
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 2.  Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature.

Authors:  Farhan Mohammad; Abhirami Vivekanandarajah; Housam Haddad; Christopher M Shutty; Matthew T Hurford; Qun Dai
Journal:  BMJ Case Rep       Date:  2014-05-19

3.  Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors.

Authors:  Francisca Ferrer-Marín; Maria Luz Amigo; Vicente Vicente
Journal:  Clin Drug Investig       Date:  2012-06-01       Impact factor: 2.859

Review 4.  Etanercept-induced leukemia: could increased mean corpuscular volume be a predictor of hematologic malignancy?

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2017-03-02       Impact factor: 2.631

5.  Psoriasis vulgaris and familial cancer risk- a population-based study.

Authors:  Romuald Maleszka; Katarzyna Paszkowska-Szczur; Ewa Soczawa; Magdalena Boer; Monika Różewicka-Czabańska; Joanna Wiśniewska; Aneta Mirecka; Lidia Krysztoforska; Zygmunt Adamski; Jan Lubinski; Tadeusz Dębniak
Journal:  Hered Cancer Clin Pract       Date:  2013-06-28       Impact factor: 2.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.